Distinct plasma phosphorylated-tau proteins profiling for the differential diagnosis of mild cognitive impairment and Alzheimer's disease by plasmonic asymmetric nanobridge-based biosensor

The differential diagnosis between mild cognitive impairment (MCI) and Alzheimer's disease (AD) has been highly demanded for its effectiveness in preventing and contributing to early diagnosis of AD. To this end, we developed a single plasmonic asymmetric nanobridge (PAN)-based biosensor to dif...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biosensors & bioelectronics 2024-04, Vol.250, p.116085-116085, Article 116085
Hauptverfasser:	Kim, Soohyun, Ma, Xingyi, Jeon, Myeong Jin, Song, Sojin, Lee, Jeong Seop, Lee, Jong Uk, Lee, Chan-Nyoung, Choi, Seong Hye, Sim, Sang Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - diagnosis Alzheimer's disease (AD) Amyloid beta-Peptides Biomarkers Biosensing Techniques Cognitive Dysfunction - diagnosis Cognitive Dysfunction - psychology Diagnosis, Differential Differential diagnosis Gold nanoparticles Humans Mild cognitive impairment (MCI) Phosphorylated-tau proteins Plasmonic biosensors tau Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!